APRIL - 17 - 2023$15www.pharmatechoutlook.comISSN 2644-2787IMMUNOTHERAPYDeka BiosciencesMADE-TO-MEASURE CYTOKINE THERAPYJohn Mumm, President and CEO
Page 2 >